首页> Scientific reports> Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.

Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Andrew,Elliott

第一单位： Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.

作者： Andrew,Elliott ^[1] ; Michelle,Saul ^[1] ; Jia,Zeng ^[1] ; John L,Marshall ^[2] ; Edward S,Kim ^[3] ; Misako,Nagasaka ^[4] ; Heinz-Josef,Lenz ^[5] ; Lee,Schwartzberg ^[6] ; David,Spetzler ^[1] ; Jim,Abraham ^[1] ; Joanne,Xiu ^[1] ; Phillip,Stafford ^[1] ; W,Michael Korn ^[7]

作者单位： Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA. ^[1] Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. ^[2] Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. ^[3] Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. ^[4] University of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA, USA. ^[5] Medical Oncology, West Cancer Center, 9745 Wolf River Blvd, Germantown, TN, USA. ^[6] Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA. wmkorn@carisls.com.;Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. wmkorn@carisls.com. ^[7]